Evaluating the effectiveness of a new drug combination in the eradication therapy for duodenal ulcer
https://doi.org/10.21518/2079-701X-2015-13-46-49
Abstract
Peptic ulcer (PU) remains the most common disease of the gastrointestinal tract. There is evidence of the pathogenic role of Helicobacter pylori (HP) in this process. PU associated with HP is an indication for eradication therapy.
About the Authors
O. N. Minushkin
Teaching and Research Medical Center of the Russian Federation Presidential Administration
Russian Federation
Russian Federation
I. V. Zverkov
Teaching and Research Medical Center of the Russian Federation Presidential Administration
Russian Federation
Russian Federation
D. V. Volodin
Teaching and Research Medical Center of the Russian Federation Presidential Administration
Russian Federation
Russian Federation
O. I. Ivanova
Teaching and Research Medical Center of the Russian Federation Presidential Administration
Russian Federation
Russian Federation
References
1. Андреев Д.Н., Кучерявый Ю.А. Факторы микро- и макроорганизма, влияющие на эффективность антихеликобактерной терапии. Consilium medicinum, 2013, 8: 5-9.
2. Васильев Ю.В. Язвенная болезнь: патологические аспекты и медикаментозное лечение. Consilium medicinum, 2002, 2: 4-10.
3. Исаков В. А. Новые рекомендации по диагностике и лечению инфекции H. pylori - Маастрихт 4. Best clinical practice (русское издание), 2012, выпуск 2: 4-23.
4. Минушкин О.Н., Зверков И.В., Володин Д.В. и др. Комбинированная эрадикационная терапия при язвенной болезни двенадцатиперстной кишки. Врач, 2008, 9: 55-57.
5. Хомерики Н.М. Маастрихт-2 и Маастрихт-3: что нужно знать практическому врачу. Фарматека, 2007, 6: 35.
Review
For citations:
Minushkin ON, Zverkov IV, Volodin DV, Ivanova OI. Evaluating the effectiveness of a new drug combination in the eradication therapy for duodenal ulcer. Meditsinskiy sovet = Medical Council. 2015;(13):46-49. (In Russ.) https://doi.org/10.21518/2079-701X-2015-13-46-49
Views:
518
Email this article 